BNTC
Benitec Biopharma Ltd ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$417.23M
P/E Ratio
—
EPS
$-1.10
Beta
0.28
52W High
$17.15
52W Low
$9.85
50-Day MA
$11.69
200-Day MA
$12.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Benitec Biopharma Ltd ADR
Benitec Biopharma Inc., a developing biotechnology company, is focused on the development of new genetic drugs. The company is headquartered in Hayward, California.
Fundamentals
| Revenue (TTM) | 7,000 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-48.30M |
| Operating Margin | 0.00% |
| Return on Equity | -33.50% |
| Return on Assets | -22.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.47 |
| Price-to-Book | 2.19 |
| Price-to-Sales (TTM) | 2823.12 |
| EV/Revenue | 10695.43 |
| EV/EBITDA | 850.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 12.50% |
| Shares Outstanding | $34.25M |
| Float | $17.83M |
| % Insiders | 2.71% |
| % Institutions | 96.47% |
Historical Volatility
HV 10-Day
38.01%
HV 20-Day
55.56%
HV 30-Day
53.73%
HV 60-Day
55.50%
HV Rank
31.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($24.17 target)
1
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026